Forte Biosciences Inc. (FBRX)
NASDAQ: FBRX
· Real-Time Price · USD
11.85
1.03 (9.52%)
At close: Aug 15, 2025, 3:59 PM
11.61
-2.03%
After-hours: Aug 15, 2025, 04:53 PM EDT
Forte Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -43.71M | -35.48M | -34.2M | -35.76M | -32.14M | -31.48M | -30.48M | -23.93M | -18.07M | -13.88M | -12.34M | -16.69M | -19.47M | -21.71M | -22.94M | -20.29M | -49.24M |
Depreciation & Amortization | 43K | 39K | 35K | 28K | 18K | 9K | 3K | n/a | n/a | n/a | n/a | 9K | 22K | 36K | 50K | 54K | 55K |
Stock-Based Compensation | 3.91M | 3.1M | 3.18M | 3.16M | 3.21M | 3.28M | 3.36M | 3.5M | 3.84M | 4.01M | 4.39M | 4.96M | 4.77M | 4.21M | 3.53M | 2.43M | 1.45M |
Other Working Capital | -948K | -1.26M | 1.4M | -207K | -1.46M | -1.33M | -204K | 1.93M | 1.38M | 1.47M | 271K | -81K | 622K | 1.01M | 1.29M | -122K | -3.23M |
Other Non-Cash Items | -143.41K | -149.41K | 4.67M | 4.55M | 4.52M | 5.22M | 1.39M | 1.95M | 3.07M | 3.81M | 5.59M | 5.21M | 5.36M | 4.5M | -1.96M | -3.37M | 26.26M |
Deferred Income Tax | n/a | n/a | -4.66M | -4.66M | -4.66M | -4.66M | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.83M | 3.83M | 3.83M |
Change in Working Capital | 1.81M | 1.76M | 1.27M | 2.06M | -1.12M | -392K | 4.62M | 4.94M | 2.81M | 1.68M | -924K | -397K | -8K | 720K | 2.4M | -1.71M | -2.74M |
Operating Cash Flow | -34.43M | -30.75M | -29.7M | -30.63M | -30.17M | -28.71M | -22.63M | -15.51M | -11.41M | -8.19M | -8.87M | -12.06M | -14.62M | -16.68M | -16.9M | -19.51M | -19.59M |
Capital Expenditures | -92K | -37K | -23K | -94K | -94K | -88K | -71K | n/a | n/a | n/a | 61K | 61K | 61K | 61K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | 3.58M |
Purchase of Investments | -35.96M | -35.96M | n/a | n/a | -9.96M | -9.96M | -9.96M | -9.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 36.35M | n/a | 1K | 10.1M | 10.1M | 10.1M | 10.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 10.1K | 134.00 | 134.00 | 134.00 | -9.96K | n/a | n/a | -61K | -61K | -61K | -61K | 3.58M | 3.58M | 3.58M |
Investing Cash Flow | 302K | -35.99M | -22K | 10.01M | 41K | 47K | 63K | -9.96M | n/a | n/a | 61K | 61K | 61K | 61K | 3.58M | 3.58M | 7.17M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 16K | n/a | -75 | -26.1K | -16.12K | -123 | -55.05K | -55.02K | -55K | -55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.47M | -1.15M | -36K | 24.75M | 24.76M | 24.77M | 24.78M | 7.45M | 7.34M | 7.3M | 7.26M | -186K | -105K | -44K | -295K | -126K | 23.97M |
Financial Cash Flow | 49.54M | 51.86M | -95K | 24.68M | 24.67M | 24.68M | 24.7M | 7.37M | 7.28M | 7.24M | 7.26M | -186K | -105K | -44K | 42.39M | 42.56M | 66.65M |
Net Cash Flow | 15.41M | -14.88M | -29.95M | 3.94M | -5.58M | -4.1M | 2.14M | -18.11M | -4.13M | -944K | -1.62M | -12.25M | -14.73M | -16.72M | 25.49M | 23.05M | 50.64M |
Free Cash Flow | -34.52M | -30.78M | -29.73M | -30.72M | -30.26M | -28.79M | -22.7M | -15.51M | -11.41M | -8.19M | -8.81M | -12M | -14.56M | -16.62M | -16.9M | -19.51M | -19.59M |